Toshifumi Ozaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Toshifumi Ozaki has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Akira Kawai
4 shared publicationsHajime Inoue
4 shared publicationsToshiyuki Kunisada
3 shared publicationsKeiichiro Nishida
2 shared publicationsA. Kawai
Department of Orthopaedic Surgery, Faculty of Medicine, Okayama University Medical School, Okayama 700-8558, Japan Tel.: +81-86-235-7273 Fax: +81-86-223-9727
1 shared publicationH. Inoue
Department of Orthopaedic Surgery, Faculty of Medicine, Okayama University Medical School, Okayama 700-8558, Japan Tel.: +81-86-235-7273 Fax: +81-86-223-9727
1 shared publication
Latest Publications
- 1 April 2001
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 385 (385) , 170-175
Reconstruction of the Proximal Humerus With the Clavicle After Tumor Resection
Reconstruction of the proximal humerus after resection for tumor and modification of the clavicular transposition procedure is described in which the blood supply of the clavicle is preserved and the clavicle is used to bridge the defect. An 11-year-old boy presented with shoulder pain, and the diagnosis was osteosarcoma of the right proximal humerus. After resection of the sarcomatous proximal humerus, the clavicle was released with its periosteum remaining intact, and the clavicle was rotated downward around the acromioclavicular joint. A vascularized fibula supplemented the reconstruction in trying to gain length of the arm. The acromioclavicular joint and the vascular supply of the clavicle were preserved. Internal fixation from the clavicle and the fibula to the distal humerus was made with an AO plate and screws. Muscles around the proximal humerus were reattached to the clavicle. Range of motion of the shoulder was 80° flexion, 85° abduction, 30° external rotation, and 90° internal rotation. Although the postoperative followup is relatively short, only 2 years, the functional advantages of this operation over other forms of reconstruction can be observed.
- 1 April 2001
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 385 (385) , 170-175
Reconstruction of the Proximal Humerus With the Clavicle After Tumor Resection
Reconstruction of the proximal humerus after resection for tumor and modification of the clavicular transposition procedure is described in which the blood supply of the clavicle is preserved and the clavicle is used to bridge the defect. An 11-year-old boy presented with shoulder pain, and the diagnosis was osteosarcoma of the right proximal humerus. After resection of the sarcomatous proximal humerus, the clavicle was released with its periosteum remaining intact, and the clavicle was rotated downward around the acromioclavicular joint. A vascularized fibula supplemented the reconstruction in trying to gain length of the arm. The acromioclavicular joint and the vascular supply of the clavicle were preserved. Internal fixation from the clavicle and the fibula to the distal humerus was made with an AO plate and screws. Muscles around the proximal humerus were reattached to the clavicle. Range of motion of the shoulder was 80° flexion, 85° abduction, 30° external rotation, and 90° internal rotation. Although the postoperative followup is relatively short, only 2 years, the functional advantages of this operation over other forms of reconstruction can be observed.
- 15 June 2000
- Published by Springer Nature in Virchows Archiv
- Vol. 436 (6) , 574-578
CD44 expression in soft tissue sarcomas.
- 15 June 2000
- Published by Springer Nature in Virchows Archiv
- Vol. 436 (6) , 574-578
CD44 expression in soft tissue sarcomas.
- 4 October 1999
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 125 (11) , 646-652
Expression of CD44 variants in osteosarcoma
The standard form of CD44 (CD44H) is a transmembranous glycoprotein, widely distributed on a variety of human lymphoid cells, epithelial cells and tumours. CD44 has many variant forms, which are generated by alternative splicing. In recent years, CD44 has been reported to be related to the degree of tumour differentiation, tumour cell invasion, and metastasis. We investigated 44 tumour specimens in 39 patients with osteosarcoma immunochemically to analyse the expression of CD44 standard (CD44H) and variant exon-encoded gene products (CD44v3, v4, v5, v6, v7, v9, and v10). Furthermore, the relationship between CD44 expression and the clinical outcome of patients with osteosarcoma was analysed. Membrane accentuation and exclusive cytoplasmic reactivity were analysed as separate staining patterns. Tumour cells and some multinucleated giant cells were markedly stained. CD44H, v3, v4, v5, v6, v7, v9, and v10 were expressed in 85%, 49%, 54%, 59%, 46%, 5%, 28%, and 10% of the specimens respectively. The cumulative 5-year metastasis-free survival was 58% in CD44v6-negative cases and 24% in CD44v6-positive cases (P=0.046). However, the cumulative 5-year metastasis-free survival was not significantly different between cases positive and negative for other variants of CD44. Multivariate analysis (Cox proportional-hazard model) with CD44v6 expression (positive or negative), chemotherapy (intensive or non-intensive), tumour site (proximal or distal), and age (at least 30 years or less than 30 years) showed that expression of CD44v6 and chemotherapy were important prognostic factors in patients with osteosarcoma. Overexpression of CD44 isoforms containing variant v6 is correlated with poor prognosis in patients with osteosarcoma.
- 4 October 1999
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 125 (11) , 646-652
Expression of CD44 variants in osteosarcoma
The standard form of CD44 (CD44H) is a transmembranous glycoprotein, widely distributed on a variety of human lymphoid cells, epithelial cells and tumours. CD44 has many variant forms, which are generated by alternative splicing. In recent years, CD44 has been reported to be related to the degree of tumour differentiation, tumour cell invasion, and metastasis. We investigated 44 tumour specimens in 39 patients with osteosarcoma immunochemically to analyse the expression of CD44 standard (CD44H) and variant exon-encoded gene products (CD44v3, v4, v5, v6, v7, v9, and v10). Furthermore, the relationship between CD44 expression and the clinical outcome of patients with osteosarcoma was analysed. Membrane accentuation and exclusive cytoplasmic reactivity were analysed as separate staining patterns. Tumour cells and some multinucleated giant cells were markedly stained. CD44H, v3, v4, v5, v6, v7, v9, and v10 were expressed in 85%, 49%, 54%, 59%, 46%, 5%, 28%, and 10% of the specimens respectively. The cumulative 5-year metastasis-free survival was 58% in CD44v6-negative cases and 24% in CD44v6-positive cases (P=0.046). However, the cumulative 5-year metastasis-free survival was not significantly different between cases positive and negative for other variants of CD44. Multivariate analysis (Cox proportional-hazard model) with CD44v6 expression (positive or negative), chemotherapy (intensive or non-intensive), tumour site (proximal or distal), and age (at least 30 years or less than 30 years) showed that expression of CD44v6 and chemotherapy were important prognostic factors in patients with osteosarcoma. Overexpression of CD44 isoforms containing variant v6 is correlated with poor prognosis in patients with osteosarcoma.
- 25 February 1999
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 4 (1) , 36-40
Effect of dose intensity of methotrexate, doxorubicin, and ifosfamide on the prognosis of patients with osteosarcoma
- 25 February 1999
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 4 (1) , 36-40
Effect of dose intensity of methotrexate, doxorubicin, and ifosfamide on the prognosis of patients with osteosarcoma
- Open Access
- 1 January 1999
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 70 (5) , 527-529
Insertion of the patella tendon after prosthetic replacement of the proximal tibia
We describe the technique and the results of a method to reconstruct the patellar tendon insertion to a tumor prosthesis by wrapping an artificial mesh around the prosthesis, followed by suturing the patellar tendon and a gastrocnemius flap to the mesh.
- 1 January 1999
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 70 (5) , 527-529
Open AccessInsertion of the patella tendon after prosthetic replacement of the proximal tibia
We describe the technique and the results of a method to reconstruct the patellar tendon insertion to a tumor prosthesis by wrapping an artificial mesh around the prosthesis, followed by suturing the patellar tendon and a gastrocnemius flap to the mesh.